Morgan Stanley Maintains Overweight on NOV, Lowers Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Elizabeth Porter maintains an Overweight rating on NOV but lowers the price target from $25 to $23.
September 16, 2024 | 5:13 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley's analyst Elizabeth Porter has maintained an Overweight rating on NOV but has lowered the price target from $25 to $23, indicating a slightly less optimistic outlook.
The lowering of the price target from $25 to $23 suggests a slightly less optimistic view on NOV's future performance, which could lead to a short-term negative impact on the stock price. However, the Overweight rating indicates continued confidence in the stock's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100